| Serial Number | 79336171 |
| Word Mark | CHIMAGENTS |
| Filing Date | Wednesday, December 8, 2021 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, September 26, 2023 |
| Registration Number | 7171768 |
| Registration Date | Tuesday, September 26, 2023 |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, July 11, 2023 |
| Goods and Services | Pharmaceuticals, namely, pharmaceuticals for the treatment of skin disorders, dermatological conditions, respiratory diseases and asthma, cancer, baldness, heart disease, cardiovascular disorders, allergies, muscle injuries and disorders, erectile dysfunction, viral diseases, hormonal disorders, infectious diseases, bone diseases, stretch marks, eye diseases and eye conditions, gastro-intestinal diseases, psychiatric diseases and disorders, immune system related diseases and disorders, insomnia, neuropathic pain, sinus congestion, blood disorders, pain, inflammation, obesity and cognitive disorders, ocular diseases or disorders, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetespyschotropics, antihelmintics, lipid lowering agents; vaccines, reagents for medical use; medical and veterinary preparations for the diagnosis and treatment of infectious diseases; sanitary preparations for medical purposes; dietetic food and beverages adapted for medical or veterinary use, food for babies; dietary supplements for human beings and animals; medical and surgical plasters; materials for dressings, namely, medical and surgical dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides |
| Goods and Services | Advertising services, namely, advertising of pharmaceuticals, reagents for medical use, medical drugs and vaccines; advertising services relating to pharmaceuticals; business management in the field of pharmaceuticals, reagents for medical use, medical drugs and vaccines; business advisory services in the field of pharmaceuticals, reagents for medical use, medical drugs and vaccines; business administration in the field of pharmaceuticals, reagents for medical use, medical drugs and vaccines; commercial consultancy in the field of pharmaceuticals, reagents for medical use, medical drugs and vaccines; commercial intermediation services in the field of pharmaceuticals, reagents for medical use, medical drugs and vaccines, namely, connecting buyers and sellers in the field of pharmaceuticals, reagents for medical use, medical drugs and vaccines; negotiating and concluding commercial transactions for others in the field of pharmaceuticals, reagents for medical use, medical drugs and vaccines; providing business assistance in the field of pharmaceutical, reagents for medical use, medical drug and vaccine product commercialization; commercial lobbying services in the field of pharmaceuticals, reagents for medical use, medical drugs and vaccines; commercial information in the field of pharmaceuticals, reagents for medical use, medical drugs and vaccines; commercial management assistance in the field of pharmaceuticals, reagents for medical use, medical drugs and vaccines; preparation of commercial reports for others in the field of pharmaceuticals, reagents for medical use, medical drugs and vaccines; collection of commercial information relating to the field of pharmaceuticals, reagents for medical use, medical drugs and vaccines into computer databases; provision of information concerning commercial sales relating to the field of pharmaceuticals, reagents for medical use, medical drugs and vaccines; compilation of business statistics and commercial information relating to the field of pharmaceuticals, medical drugs and vaccines; business management consultancy and advisory services relating to the field of pharmaceuticals, medical drugs and vaccines; business management of reimbursement programmes for others relating to the field of pharmaceuticals, reagents for medical use, medical drugs and vaccines; business administration of medication reimbursement programs and services; provision of an online marketplace for buyers and sellers of pharmaceuticals, reagents for medical use, medical drugs and vaccines; sales promotion of pharmaceuticals, reagents for medical use, medical drugs and vaccines; business opportunity promotion of pharmaceuticals, reagents for medical use, medical drugs and vaccines; promotion services being marketing services; promotional and advertising services; promoting the sale of goods and services of others through promotional events in the field of pharmaceuticals, reagents for medical use, medical drugs and vaccines; database management relating to pharmaceuticals, reagents for medical use, medical drugs, vaccines and medical trials; retail and wholesale store services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies; retail and wholesale store services relating to medical instruments and devices, pharmaceuticals, reagents for medical use, drugs and vaccines |
| Goods and Services | Scientific and technological services, namely, research relating to pharmaceuticals, reagents for medical use, medical drugs, vaccines and medical trials, and design relating thereto; industrial analysis and industrial research services in the field of pharmaceuticals, reagents for medical use, medical drugs, vaccines and medical trials; preparation of technical reports relating to pharmaceuticals, reagents for medical use, drugs and vaccines, namely, technical writing; technical research relating to pharmaceuticals, reagents for medical use, medical drugs and vaccines; providing scientific information in the field of medical disorders and their treatment; medical and pharmacological research services; medical research relating to pharmaceuticals, reagents for medical use, medical drugs and vaccines; scientific research for medical purposes, namely, medical research; provision of scientific information and data relating to medical and veterinary research and development; research and development in the field of biotechnology; biotechnology testing, namely consumer product testing in the field of biotechnology; testing of pharmaceuticals; technical testing services relating to pharmaceuticals, reagents for medical use, medical drugs and vaccines; testing, authentication and quality control of pharmaceuticals, reagents for medical use, medical drugs and vaccines; consultancy relating to biotechnology; medical laboratory services; product design and development in the field of medical technology; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; clinical trials, namely, scientific research in the nature of conducting clinical trials for others; research and development of vaccines and medicines; drug discovery services; pharmaceutical drug development services; pharmaceutical research services; pharmaceutical product evaluation; pharmaceutical research and development services |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, March 24, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, March 24, 2022 |
| Primary Code | 035 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, March 24, 2022 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | OPEN ORPHAN PLC |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | GB |
| Party Name | OPEN ORPHAN PLC |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | GB |
| Party Name | OPEN ORPHAN PLC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | GB |
| Event Date | Event Description |
| Monday, January 22, 2024 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Friday, December 29, 2023 | FINAL DISPOSITION NOTICE SENT TO IB |
| Friday, December 29, 2023 | FINAL DISPOSITION PROCESSED |
| Tuesday, December 26, 2023 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Tuesday, September 26, 2023 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Tuesday, September 26, 2023 | REGISTERED-PRINCIPAL REGISTER |
| Monday, September 11, 2023 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
| Wednesday, August 23, 2023 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Wednesday, August 23, 2023 | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
| Tuesday, July 11, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, July 11, 2023 | PUBLISHED FOR OPPOSITION |
| Monday, July 10, 2023 | NOTIFICATION PROCESSED BY IB |
| Tuesday, June 20, 2023 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Wednesday, June 21, 2023 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Wednesday, June 21, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Wednesday, June 7, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, May 24, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, May 24, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, May 24, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, December 22, 2022 | REFUSAL PROCESSED BY IB |
| Saturday, November 26, 2022 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Saturday, November 26, 2022 | REFUSAL PROCESSED BY MPU |
| Tuesday, September 20, 2022 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Monday, September 19, 2022 | NON-FINAL ACTION WRITTEN |
| Friday, September 16, 2022 | ASSIGNED TO EXAMINER |
| Tuesday, March 29, 2022 | APPLICATION FILING RECEIPT MAILED |
| Thursday, March 24, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, March 17, 2022 | SN ASSIGNED FOR SECT 66A APPL FROM IB |